Following the negative impact of the COVID-19 pandemic, the US foot and ankle orthopedic device market will be supported by sustained growth in high-volume segments driven by implant innovations and changing patient and surgeon preferences. The ongoing shift of foot and ankle procedures to outpatient and ASC settings will drive procedure volumes, contributing to revenue expansion in this market over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the state of the US market for foot and ankle orthopedic devices from 2019 to 2031.
The COVID-19 pandemic has affected the foot and ankle orthopedic device market.
To what extent has the US foot and ankle orthopedic device market recovered from the impact of COVID-19?
How quickly have procedure volumes recovered?
When will each market segment return to levels seen prior to the pandemic?
The shift of foot and ankle procedures to outpatient and ASC settings is driven by patient and payer demand for lower cost.
How have CMS changes to reimbursement in recent years impacted procedure volumes?
How have these policies impacted the shift of procedures to the outpatient and ASC settings?
How are manufacturers catering to different sites-of-service?
The US foot and ankle orthopedic device market will be driven by sustained growth in certain high-volume segments.
Which indications contribute most strongly to overall procedure volumes?
Which surgical techniques do physicians prefer to use to treat these indications?
Which companies are launching next-generation implants for these indications?
The foot and ankle market is growing due to increased adoption of premium devices.
Which segments are seeing increased adoption of premium implants?
Which product innovations are competitors pursuing?
How is the shift in site-of-service impacting the adoption of premium implants?
Large competitors have solidified their market shares through acquisitions and mergers.
What does the competitive landscape look like for each segment? Which companies are using mergers and acquisitions to stay competitive in the market?
Which competitors have recently engaged in acquisitions or partnership activities?
How are smaller competitors faring in the foot and ankle device market?